AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2017
Jul 7, 2017
35124_dirs_2017-07-07_20c36b6e-13a7-47ba-8593-4929959ca7c9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2017-07-07
Reporting Person: Fritz Frederick J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-07 | Celsion Corporation Common Stock | P | 6500 | $1.88 | Acquired | 9841 | Direct |
| 2017-07-07 | Celsion Corporation Common Stock | P | 6500 | $1.90 | Acquired | 6500 | Indirect |
Footnotes
F1: The shares were purchased by the reporting person on the open market.
F2: Stock purchased by spouse for Roth IRA. Mr. Fritz disclaims beneficial ownership of all shares held by his spouse.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23